A Multi-Center Phase Ib Study of Oxaliplatin (NSC#266046) in Combination with Fluorouracil and Leucovorin in Pediatric Patients with Advanced Solid Tumors

BACKGROUND: Platinum agents have been used for a variety of cancers, including pivotal use in pediatric tumors for many years. Oxaliplatin, a third generation platinum, has a different side effect profile and may provide improved activity in pediatric cancers. PROCEDURE: Patients 21 years or younger...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Macy, Margaret E., Duncan, Tracey, Whitlock, James, Hunger, Stephen P., Boklan, Jessica, Narendren, Aru, Herzog, Cynthia, Arceci, Robert J., Bagatell, Rochelle, Trippett, Tanya, Christians, Uwe, Rolla, Katherine, Ivy, S. Percy, Gore, Lia
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2012
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3522763/
https://ncbi.nlm.nih.gov/pubmed/23024067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24278
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन